Encompass Health Corp EHC
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $5.9B | +10% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Operating income | $539.5M | -4% | FY ending Dec 31, 2022 |
| Net income | $566.2M | +24% | FY ending Dec 31, 2025 |
| Earnings per share | $5.54 | +24% | FY ending Dec 31, 2025 |
| Cash from operations | $705.8M | -1% | FY ending Dec 31, 2022 |
| Capital spending | $564.8M | +8% | FY ending Dec 31, 2022 |
| Share buybacks | $158.0M | +408% | FY ending Dec 31, 2025 |
| Dividends paid | $71.1M | +13% | FY ending Dec 31, 2025 |
| Cash | $72.2M | -15% | FY ending Dec 31, 2025 |
| Long-term debt | $1.2B | -17% | FY ending Dec 31, 2011 |
| Shareholders' equity | $2.4B | +18% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 10 sales ($47.8M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Andrew L PriceChief Accounting Officer | Sold | 5,211 | $120.93 | $630K | Aug 31, 2026 |
| John Patrick DarbyEVP, Gen Counsel & Secretary | Sold | 4,858 | $121.09 | $588K | Aug 31, 2026 |
| Mark J TarrPresident & CEO, Director | Sold2 fills | 173,148 | $125.47 avg | $21.7M | Aug 10, 2026 |
| Douglas E ColtharpEVP & Chief Financial Officer | Sold | 18,869 | $125.38 | $2.4M | Aug 10, 2026 |
| John Patrick DarbyEVP, Gen Counsel & Secretary | Sold | 8,906 | $125.95 | $1.1M | Aug 10, 2026 |
| Douglas E ColtharpEVP & Chief Financial Officer | Sold2 fills | 27,694 | $106.83 avg | $3.0M | May 15, 2026 |
| Patrick William TuerEVP, Chief Operating Officer | Sold | 682 | $104.56 | $71K | May 11, 2026 |
| Edmund FaySr. Vice Pres. and Treasurer | Sold | 11,937 | $107.00 | $1.3M | Mar 9, 2026 |
| Mark J TarrPresident & CEO, Director | Sold7 fills | 150,000 | $111.64 avg | $16.7M | Feb 11, 2026 |
| Patrick William TuerEVP, Chief Operating Officer | Sold | 2,804 | $107.62 | $302K | Feb 10, 2026 |
Other insider moves (96): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Christopher R ReidyDirector | Award | 284 | $126.89 | $36K | Oct 19, 2026 |
| Edward M Iii ChristieDirector | Award | 221 | $126.63 | $28K | Oct 19, 2026 |
| Greg D CarmichaelDirector | Award | 28 | – | – | Oct 15, 2026 |
| Terrance WilliamsDirector | Award | 28 | – | – | Oct 15, 2026 |
| Nancy M SchlichtingDirector | Award | 38 | – | – | Oct 15, 2026 |
| Joan E HermanDirector | Award | 81 | – | – | Oct 15, 2026 |
| Edward M Iii ChristieDirector | Award | 11 | – | – | Oct 15, 2026 |
| Christopher R ReidyDirector | Award | 20 | – | – | Oct 15, 2026 |
| Cain A HayesDirector | Award | 4 | – | – | Oct 15, 2026 |
| Kevin J. O'ConnorDirector | Award | 18 | – | – | Oct 15, 2026 |
| Leslye G KatzDirector | Award | 81 | – | – | Oct 15, 2026 |
| John Patrick DarbyEVP, Gen Counsel & Secretary | Option exercise | 4,858 | $35.06 | $170K | Aug 31, 2026 |
| Christopher R ReidyDirector | Award | 319 | $112.40 | $36K | Jul 16, 2026 |
| Edward M Iii ChristieDirector | Award | 248 | $112.43 | $28K | Jul 16, 2026 |
| Christopher R ReidyDirector | Award | 21 | – | – | Jul 15, 2026 |
| Edward M Iii ChristieDirector | Award | 11 | – | – | Jul 15, 2026 |
| Terrance WilliamsDirector | Award | 29 | – | – | Jul 15, 2026 |
| Nancy M SchlichtingDirector | Award | 40 | – | – | Jul 15, 2026 |
| Kevin J. O'ConnorDirector | Award | 19 | – | – | Jul 15, 2026 |
| Leslye G KatzDirector | Award | 85 | – | – | Jul 15, 2026 |
| Joan E HermanDirector | Award | 85 | – | – | Jul 15, 2026 |
| Cain A HayesDirector | Award | 4 | – | – | Jul 15, 2026 |
| Greg D CarmichaelDirector | Award | 29 | – | – | Jul 15, 2026 |
| Douglas E ColtharpEVP & Chief Financial Officer | Option exercise | 27,694 | $32.94 | $912K | May 15, 2026 |
| Kevin J. O'ConnorDirector | Award | 1,634 | – | – | May 7, 2026 |
| Edward M Iii ChristieDirector | Award | 1,634 | – | – | May 7, 2026 |
| Christopher R ReidyDirector | Award | 1,634 | – | – | May 7, 2026 |
| Cain A HayesDirector | Award | 1,634 | – | – | May 7, 2026 |
| Greg D CarmichaelDirector | Award | 1,634 | – | – | May 7, 2026 |
| Terrance WilliamsDirector | Award | 1,634 | – | – | May 7, 2026 |
| Leslye G KatzDirector | Award | 1,634 | – | – | May 7, 2026 |
| Joan E HermanDirector | Award | 1,634 | – | – | May 7, 2026 |
| Nancy M SchlichtingDirector | Award | 1,634 | – | – | May 7, 2026 |
| Christopher R ReidyDirector | Award | 334 | $106.48 | $36K | Apr 16, 2026 |
| Edward M Iii ChristieDirector | Award | 261 | $106.17 | $28K | Apr 16, 2026 |
| Greg D CarmichaelDirector | Award | 27 | – | – | Apr 15, 2026 |
| Edward M Iii ChristieDirector | Award | 9 | – | – | Apr 15, 2026 |
| Cain A HayesDirector | Award | 1 | – | – | Apr 15, 2026 |
| Joan E HermanDirector | Award | 85 | – | – | Apr 15, 2026 |
| Leslye G KatzDirector | Award | 85 | – | – | Apr 15, 2026 |
| Kevin J. O'ConnorDirector | Award | 17 | – | – | Apr 15, 2026 |
| Christopher R ReidyDirector | Award | 19 | – | – | Apr 15, 2026 |
| Nancy M SchlichtingDirector | Award | 39 | – | – | Apr 15, 2026 |
| Terrance WilliamsDirector | Award | 27 | – | – | Apr 15, 2026 |
| Edmund FaySr. Vice Pres. and Treasurer | Gift | 3,000 | – | – | Mar 9, 2026 |
| Mark J TarrPresident & CEO, Director | Tax withholding | 2,187 | $107.88 | $236K | Feb 28, 2026 |
| Douglas E ColtharpEVP & Chief Financial Officer | Tax withholding | 776 | $107.88 | $84K | Feb 28, 2026 |
| Patrick William TuerEVP, Chief Operating Officer | Tax withholding | 545 | $107.88 | $59K | Feb 28, 2026 |
| John Patrick DarbyEVP, Gen Counsel & Secretary | Tax withholding | 416 | $107.88 | $45K | Feb 28, 2026 |
| Elissa Joy CharbonneauChief Medical Officer | Tax withholding | 369 | $107.88 | $40K | Feb 28, 2026 |
| Andrew L PriceChief Accounting Officer | Tax withholding | 307 | $107.88 | $33K | Feb 28, 2026 |
| Edmund FaySr. Vice Pres. and Treasurer | Tax withholding | 280 | $107.88 | $30K | Feb 28, 2026 |
| Douglas E ColtharpEVP & Chief Financial Officer | Tax withholding | 14,818 | $106.15 | $1.6M | Feb 23, 2026 |
| John Patrick DarbyEVP, Gen Counsel & Secretary | Tax withholding | 6,990 | $106.15 | $742K | Feb 23, 2026 |
| Mark J TarrPresident & CEO, Director | Tax withholding | 2,488 | $106.15 | $264K | Feb 23, 2026 |
| Patrick William TuerEVP, Chief Operating Officer | Tax withholding | 506 | $106.15 | $54K | Feb 23, 2026 |
| Elissa Joy CharbonneauChief Medical Officer | Tax withholding | 440 | $106.15 | $47K | Feb 23, 2026 |
| Andrew L PriceChief Accounting Officer | Tax withholding | 404 | $106.15 | $43K | Feb 23, 2026 |
| Edmund FaySr. Vice Pres. and Treasurer | Tax withholding | 380 | $106.15 | $40K | Feb 23, 2026 |
| Mark J TarrPresident & CEO, Director | Tax withholding | 1,797 | $106.55 | $191K | Feb 20, 2026 |
Trades by members of Congress
1 member reported 2 buys and 2 sales since Jul 22, 2025. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 31, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Jul 22, 2025 | Aug 13, 2025 | Spouse |
Latest SEC filings
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Oct 28, 2026
- Insider plans to sell 144 · Aug 31, 2026
- News filing: Other news 8-K · Aug 13, 2026
- Insider plans to sell 144 · Aug 10, 2026
- Insider plans to sell 144 · Aug 10, 2026
- Insider plans to sell 144 · Aug 10, 2026
- Quarterly report 10-Q · Aug 7, 2026
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Aug 5, 2026
- News filing: Signed a major agreement, Took on new debt 8-K · Jun 1, 2026
- News filing: Signed a major agreement, Other news 8-K · May 15, 2026
- Insider plans to sell 144 · May 15, 2026
- Insider plans to sell 144 · May 11, 2026
- News filing: Shareholder vote results 8-K · May 11, 2026
- Quarterly report 10-Q · May 1, 2026
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Apr 30, 2026
- Shareholder meeting proxy DEF 14A · Apr 7, 2026
- News filing: Signed a major agreement, Ended a major agreement, Took on new debt 8-K · Mar 10, 2026
- Annual report 10-K · Feb 26, 2026
- Insider plans to sell 144 · Feb 11, 2026
- Insider plans to sell 144 · Feb 10, 2026
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Feb 5, 2026
- News filing: Executive or board change 8-K · Feb 2, 2026
- News filing: Public announcement (Reg FD) 8-K · Dec 1, 2025
- Quarterly report 10-Q · Oct 31, 2025
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Oct 29, 2025
About Encompass Health Corp
Business description
- Industry
- Services-Hospitals
- Sector
- Industrial Applications and Services
- Headquarters
- Birmingham, AL
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Exchange
- NYSE
- Filer size
- Large accelerated filer
- Formerly
- HEALTHSOUTH CORP, HEALTHSOUTH REHABILITATION CORP
- SEC company number (CIK)
- 785161
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.